Self-reported activity of Swedish persons with haemophilia: Change over 2.5 years.

OBJECTIVES To describe self-reported activity using the Haemophilia Activity List (HAL) for Swedish adults with haemophilia and to detect any changes over time. METHOD The HAL was sent to the adult population with haemophilia A and B, moderate and severe form, living in Sweden (n = 260). Participants completed the HAL and a questionnaire on sociodemographic and medical information. From a previous study cohort, 61 persons had responded twice to the HAL. The investigated group was divided into early and later treatment onset groups with regard to access to medication. RESULTS The response rate was 50%. There was a significant difference (p < 0.001) between the early and later treatment groups in all domains in HAL. When analysing HAL "question by question" from the 2 reported time-points, the most prominent outcome was that the reported ability in activities was stable over time at the group level, except for participants who had no access to the clotting factor early in life. They reported greater limitations in some of the activities in the challenging domain "leisure activities and sport". CONCLUSION The early treatment group reported a significantly better ability in all activities compared with the late treatment group.

[1]  K. Sunnerhagen,et al.  Self‐reported activity and functioning in daily life; the perspective of persons with haemophilia living in Sweden , 2015, European journal of haematology.

[2]  E. Berntorp,et al.  The ageing patient with haemophilia , 2015, European journal of haematology.

[3]  E. Berntorp,et al.  Outcome measures in haemophilia: a systematic review , 2014, European journal of haematology. Supplementum.

[4]  V. Blanchette,et al.  Assessment of outcomes , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[5]  E. Lindeman,et al.  Long‐term outcome of multiple joint procedures in haemophilia , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[6]  C. Hermans,et al.  Clinical management of older persons with haemophilia. , 2014, Critical reviews in oncology/hematology.

[7]  R. Ljung,et al.  Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s. , 2013, Blood.

[8]  E. Berntorp,et al.  Quality of life in adult patients with haemophilia – a single centre experience from Sweden , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[9]  J. Astermark,et al.  Recommendations for assessment, monitoring and follow‐up of patients with haemophilia , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[10]  Jeffrey S. Stonebraker,et al.  A study of variations in the reported haemophilia B prevalence around the world , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[11]  K. Sunnerhagen,et al.  The Swedish version of the Haemophilia Activity List , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

[12]  Asghar Amanpour,et al.  Fish. , 2011, Diabetes forecast.

[13]  R. Kaufman,et al.  Cellular Processing of Factor VIII and Factor IX , 2010 .

[14]  Jeffrey S. Stonebraker,et al.  A study of variations in the reported haemophilia A prevalence around the world , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[15]  A. Viswabandya,et al.  Psychometric analysis of the Functional Independence Score in Haemophilia (FISH) , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

[16]  B. Feldman,et al.  Hemophilia joint health score reliability study , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[17]  P. Helders,et al.  Measuring patients’ perceptions on their functional abilities: validation of the Haemophilia Activities List , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[18]  P. Helders,et al.  Functional consequences of haemophilia in adults: the development of the Haemophilia Activities List , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

[19]  F. Rosendaal,et al.  Definitions in Hemophilia , 2001, Thrombosis and Haemostasis.

[20]  E Svensson,et al.  Ordinal invariant measures for individual and group changes in ordered categorical data. , 1998, Statistics in medicine.

[21]  E. Svensson Analysis of systematic and random differences between paired ordinal categorical data , 1995 .

[22]  H. Pettersson,et al.  Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and B , 1992, Journal of internal medicine.

[23]  Å. Ahlberg,et al.  HAEMOPHILIA PROPHYLAXIS IN SWEDEN , 1976, Acta paediatrica Scandinavica.

[24]  H. Egli Treatment of hemophilia A and B. , 1965, Bibliotheca haematologica.